Skip to main content

Table 4 Complete response of DLM

From: Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review

Ref.

Patients with DLM (%)

Initial CRLM

DLM

DLM/patient

CPR/resected DLM

CCR/DLM left in situ

Time to recurrence

Median follow-up (months)

DLM with CR

DLM with CR + IOUS

Elias et al. [14]

15 (14)

n.s.

n.s.

n/a

n/a

8/11 patients

5, 5, 8 months

31

n/a

n/a

Benoist et al. [13]

38 (7)

183

66

1.7

3/15

8/31

n.s.

12

17%

24%

Elias et al. [15]

16 (7)

134

69

4.3

n/a

10/16 patients

n.s.

50

n/a

n/a

Auer et al. [16]

39 (9)

166

118

3

44/68

31/50

Mean 21 months

41

64%

65%

Tanaka et al. [17]

23 (37)

472

86

3.7

6/17

16/27

Median 14 months

44

69%

80%

Goèré et al. [18]

27 (n/a)

523

96

3.6

n/a

18/27

Median 14 months

55

n/a

n/a

van Vledder et al. [19]

40 (24)

n.s

127

3.2

26/67

24/45

n.s.

20

45%

54%

Ferrero et al. [20]

33 (19)

624

67

2

22/57

4/10

Within 12 months

n.s.

39%

64%

Park et al. [21]

87 (n/a)

393

CT: 203, MRI: 55

0.6 (MRI)

CT: 47/168, MRI: 28/39

CT: 24/35, MRI: 15/16

Within 12 months

12

CT: 35%, MRI: 78%

CT: 69%, MRI: 94%

Kim et al. [22]

43 (31)

289

168

3.9

8/8

128/150

n.s.

22

85%

n/a

Arita et al. [23]

11 (15)

234

32

0.4

10/37

4/7

n.s.

n.s.

41%

IOUS: 46%, CE-IOUS: 75%

Owen et al. [24]

11 (48)

200

77

7

10/36

20/41

n.s.

46

40%

n/a

Tani et al. [9]

20 (24)

619

111

5.6

CT: 54/78, MRI: 24/29

CT: 11/33, MRI: 16/18

Median 8 months

27

CT: 59%, +MRI: 85%

86%

Sturesson et al. [25]

29 (16)

141

66

2.3

24/56

3/4

n.s.

n.s.

45%

96%

Oba et al. [8]

59 (32)

764

275

4.7

103/233

36/42

n.s.

27

CT: 51%, +MRI: 65%

92%

  1. DLM disappearing liver metastases, CRLM colorectal liver metastases, CPR complete pathological response, CCR complete clinical response, CR complete response, n.s. not stated, n/a not applicable, IOUS intraoperative ultrasound, CE-CT contrast-enhanced computed tomography, MRI magnetic resonance imaging, EOB-MRI gadoxetic acid-enhanced magnetic resonance imaging, CE-IOUS contrast-enhanced intraoperative ultrasound